Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
RESEARCH TOOLSreports
Firebrick Pharma Limited (FRE) Share Price & Analysis
1 Followers
FRE Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.04 - AU$0.36
Previous CloseAU$0.06
Volume17.02K
Average Volume (3M)289.42K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)AU$7.14M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-2.3
Beta0.71
Next Earnings
Aug 15, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume289,421
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Firebrick Pharma Limited News
PremiumCompany Announcements
Firebrick Pharma Advances Nasodine Market Approval
PremiumCompany Announcements
Firebrick Pharma Plans New ASX Securities Quotation
PremiumCompany Announcements
Firebrick Pharma Launches Nasodine in the US
PremiumCompany Announcements
Firebrick Pharma Launches Nasodine Spray in USOptions Prices
Currently, No data available
---
Ownership Overview
34.42% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
65.58% Public Companies and
Individual Investors
FRE FAQ
What was Firebrick Pharma Limited’s price range in the past 12 months?
Firebrick Pharma Limited lowest share price was AU$0.04 and its highest was AU$0.36 in the past 12 months.
What is Firebrick Pharma Limited’s market cap?
Currently, no data Available
When is Firebrick Pharma Limited’s upcoming earnings report date?
Firebrick Pharma Limited’s upcoming earnings report date is Aug 15, 2024 which is in 102 days.
How were Firebrick Pharma Limited’s earnings last quarter?
Firebrick Pharma Limited released its earnings results on Feb 28, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Firebrick Pharma Limited overvalued?
According to Wall Street analysts Firebrick Pharma Limited’s price is currently Overvalued.
Does Firebrick Pharma Limited pay dividends?
Firebrick Pharma Limited does not currently pay dividends.
What is Firebrick Pharma Limited’s EPS estimate?
Firebrick Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firebrick Pharma Limited have?
Firebrick Pharma Limited has 179,306,730 shares outstanding.
What happened to Firebrick Pharma Limited’s price movement after its last earnings report?
Firebrick Pharma Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Firebrick Pharma Limited?
Currently, no hedge funds are holding shares in AU:FRE
---
Firebrick Pharma Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:FRE Sentiment 92%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.20%
12-Months-Change
Fundamentals
Return on Equity
-136.04%
Trailing 12-Months
Asset Growth
-65.42%
Trailing 12-Months
Company Description
Firebrick Pharma Limited
Firebrick Pharma Ltd is an Australian pharmaceutical developer. The company has developed a nasal spray medicine that targets the viral cause of the common cold.
---
Technical Analysis
Recce Pharmaceuticals Ltd.
―
Sonic Healthcare Limited
―
LBT Innovations Limited
―
Invex Therapeutics Ltd.
―
---